RPTH Journal/LinkedIn
Nov 9, 2025, 10:18
RPTH Study Finds 3× Cancer Risk in Migraine Patients After VTE
RPTH Journal posted on LinkedIn:
”Patients with migraines have a higher risk of venous clots.
Oscar Rosenkrantz and team examined if cancer risk after clot was still elevated. They found in a Danish cohort that risk was 3x higher in year one vs expected rates, suggesting occult cancer may still explain clots.
Read the study here.
Title: Venous thromboembolism and cancer risk in patients with a history of migraine: a population-based cohort study
Authors: Oscar Rosenkrantz, Dóra K. Farkas, Erzsébet Horváth-Puhó, Søren K. Martiny, Holly Elser, Cecilia H. Fuglsang, Henrik T. Sørensen”
Stay updated with Hemostasis Today.
Blood Clots
cancer
Cancer Risk
Cecilia H. Fuglsang
Dóra K. Farkas
Erzsébet Horváth-Puhó
Health
Hematology
Hemostasis
Hemostasis Today
Henrik T. Sørensen
Holly Elser
International Society on Thrombosis and Haemostasis
ISTH
Medicine
Migraine
Oscar Rosenkrantz
rpth
RPTH Journal
Søren K. Martiny
thrombosis
venous thromboembolism
-
Jan 6, 2026, 13:39JAMA Neurology: No Added Benefit of Dual Therapy After Ischemic Stroke in Case of AFib
-
Jan 6, 2026, 10:10This is Fantastic: Shirley D’Sa on Transfusion-Free Christmas Milestone for 𝛃-Thalassaemia Patient at UCLH
-
Jan 6, 2026, 09:53Hamideh Yadegari: Coagulation–Inflammation Crosstalk: Mechanisms, Pathways, and Clinical Implications
-
Jan 6, 2026, 09:52Antoine Francis: Plasma is Not Just Another Component of Healthcare…
-
Jan 6, 2026, 09:45Hurry to Join EHC Youth Leadership Workshop 2026
-
Jan 6, 2026, 09:41Andrew Petrosoniak Makes It to N1 on EMCases Best of 2025!
-
Jan 6, 2026, 09:35Sara Ng: Moving Beyond Management to Stewardship – “Advancing Anticoagulation Stewardship” Released by NQF
-
Jan 6, 2026, 09:30Wolfgang Miesbach: Excellent 4-Year Data of Etranacogene Dezaparvovec in Haemophilia B
-
Jan 6, 2026, 09:09Abdulrahman Nasiri: A New Perspective on Avatrombopag in Aplastic Anemia